{
    "clinical_study": {
        "@rank": "51861", 
        "arm_group": [
            {
                "arm_group_label": "Standard of Care", 
                "arm_group_type": "No Intervention", 
                "description": "Standard of Care Arm - subjects treated by routine manner"
            }, 
            {
                "arm_group_label": "LifeSeal\u2122 Kit", 
                "arm_group_type": "Experimental", 
                "description": "LifeSeal\u2122 Kit Arm - subjects treated with the LifeSeal\u2122 Kit device + Standard of Care treatment"
            }
        ], 
        "brief_summary": {
            "textblock": "A preliminary Study in Subjects Undergoing Low Anterior Resection"
        }, 
        "brief_title": "LifeSeal\u2122 Preliminary Study in Subjects Undergoing Low Anterior Resection", 
        "completion_date": {
            "#text": "August 2013", 
            "@type": "Actual"
        }, 
        "condition": "Rectal Cancer", 
        "condition_browse": {
            "mesh_term": "Rectal Neoplasms"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Subject, or authorized representative, signed a written Informed Consent\n\n          2. Subject is at least 18 years of age\n\n          3. Subject is scheduled for elective open resection\n\n          4. Stapled anastomosis created within 10cm of the anal verge\n\n          5. Subject is willing to comply with the follow-up requirements of the study\n\n        Exclusion Criteria:\n\n          1. Subject has a history of hypersensitivity to porcine derived gelatin or collagen\n\n          2. Subject has unacceptable baseline hematological results\n\n          3. Subject on chronic preoperative treatment with steroids and anticoagulants\n\n          4. Subject with elevated liver function tests\n\n          5. Subject with abnormal kidney function\n\n          6. Subject with a BMI higher than 35\n\n          7. Subject participating in any other study for either drug or device which can\n             influence collection of valid data under this study\n\n          8. Subject with a history of MI, CVA or ASA status IV or a life expectancy of less than\n             1 year\n\n          9. Anastomosis was performed differently from what was defined\n\n         10. Subject received intraoperative sealant, glue or any buttressing material for the\n             study related anastomosis, other than the LifeSeal\u2122\n\n         11. Subject has intraoperative bleeding in excess of 500cc\n\n         12. Subject has peritoneal carcinomatosis"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "January 31, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01790230", 
            "org_study_id": "CLP-LS-0105"
        }, 
        "intervention": {
            "arm_group_label": "LifeSeal\u2122 Kit", 
            "description": "Application of LifeSeal\u2122 Kit for staple line reinforcement during open GI surgeries in Low Anterior Resection", 
            "intervention_name": "LifeSeal\u2122 Kit", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "September 1, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Uppsala", 
                    "country": "Sweden", 
                    "zip": "SE-751 85"
                }, 
                "name": "Uppsala University Hospital"
            }
        }, 
        "location_countries": {
            "country": "Sweden"
        }, 
        "number_of_arms": "2", 
        "official_title": "LifeSeal\u2122 Preliminary Study in Subjects Undergoing Low Anterior Resection", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Sweden: Medical Products Agency"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Assessment of subject's safety by incidence of related Adverse Events", 
            "safety_issue": "Yes", 
            "time_frame": "Approx. 1 month"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01790230"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Surgeon will complete a questionnaire regarding the device use and ease of application", 
            "measure": "Assessment of the device's application technique", 
            "safety_issue": "No", 
            "time_frame": "Intra-operative"
        }, 
        "source": "LifeBond Ltd.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "LifeBond Ltd.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}